The findings reviewed by GME stated that the Global Metabolomics Market will expand with a CAGR value of 13.6%. Increasing incidences of cancer and other chronic diseases have resulted in increased funding for research in the metabolomics field. The growing technological advancement and acceptance of metabolomics solutions have resulted in the growth of the metabolomics market.
Browse 159 Market Data Tables and 119 Figures
spread through 189 Pages and in-depth TOC on "Metabolomics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-metabolomics-market-2764
By Product & Service (Metabolomics Instruments
[Separation Tools {Gas Chromatography, High-Performance Liquid Chromatography,
Ultra-Performance Liquid Chromatography, Capillary Electrophoresis}, Detection
Tools {Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS),
Surface-Based Mass Analysis}, Bioinformatics Tools and Services {Bioinformatics
Services, Bioinformatics Tools and Databases}] and Services), By Application
(Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics,
Functional Genomics, Personalized Medicine, Other Applications), By Indication
(Cancer, Cardiovascular Disorders, Neurological Disorders, Metabolic Disorders,
Inborn Errors of Metabolism, Other Indications), By End-User (Academic and
Research Institutes, Pharmaceutical & Biotechnology Companies, Contract
Research Organizations, Other End-Users), By Company Type (Tier 1 Pharmaceutical
Companies, Tier 2 Pharmaceutical Companies, Tier 3 Pharmaceutical Companies),By
Region (North America,
Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape,
Company Market Share Analysis & Competitor Analysis
Key Market Insights
·
Metabolomicsis the study of metabolites to study
and identify the physiology of the body and the market is anticipated to grow
with the CAGR value of 13.6%.
·
Cancer is the
fastest and largest indication segment in the market
·
As per the application outlook, it is analyzed the
biomarker discovery segment will be the dominant of all in terms of market
value/revenue
Browse the
Report @ https://www.globalmarketestimates.com/market-report/global-metabolomics-market-2764
Products & Services Outlook (Revenue, USD
Billion, 2021-2026)
·
Metabolomics
Instruments
·
Separation Tools
·
Gas Chromatography
·
High-Performance
Liquid Chromatography
·
Ultra-Performance
Liquid Chromatography
·
Capillary
Electrophoresis
·
Detection Tools
·
Nuclear Magnetic
Resonance (NMR) Spectroscopy
·
Mass Spectrometry (MS)
·
Surface-Based Mass
Analysis
·
Bioinformatics Tools
and Services
·
Bioinformatics
Services
·
Bioinformatics Tools
and Databases
·
Metabolomics Services
Application Outlook (Revenue, USD Billion,
2021-2026)
·
Biomarker Discovery
·
Drug Discovery
·
Toxicology Testing
·
Nutrigenomics
·
Functional Genomics
·
Personalized Medicine
·
Other Applications
Indication Outlook (Revenue, USD Billion,
2021-2026)
·
Cancer
·
Cardiovascular
Disorders
·
Neurological Disorders
·
Metabolic Disorders
·
Inborn Errors of
Metabolism
·
Other Indications
End-User Outlook (Revenue, USD Billion,
2021-2026)
·
Academic and Research
Institutes
·
Pharmaceutical &
Biotechnology Companies
·
Contract Research
Organizations
·
Other End-Users
Company Type Outlook (Revenue, USD Billion,
2021-2026)
·
Tier 1 Pharmaceutical
Companies
·
Tier 2 Pharmaceutical
Companies
·
Tier 3 Pharmaceutical
Companies
Regional Outlook
(Revenue, USD Billion, 2021-2026)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of APAC
Central
& South America
- Brazil
- Argentina
- Rest of CSA
Middle
East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Contact:
Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment